 Connection
Joshua Barocas to Hepatitis C
This is a "connection" page, showing publications Joshua Barocas has written about Hepatitis C.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.986 |
|
|
|
-
Barocas JA, Savinkina A, Lodi S, Epstein RL, Bouton TC, Sperring H, Hsu HE, Jacobson KR, Schechter-Perkins EM, Linas BP, White LF. Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study. Clin Infect Dis. 2022 08 24; 75(1):e1112-e1119.
Score: 0.677
-
Barocas JA. 100-100-100: a new, ambitious treatment target to end the HIV and hepatitis C epidemics. Lancet Public Health. 2022 02; 7(2):e98-e99.
Score: 0.649
-
Barocas JA. It's Not Them, It's Us: Hepatitis C Reinfection Following Successful Treatment Among People Who Inject Drugs. Clin Infect Dis. 2021 04 26; 72(8):1401-1403.
Score: 0.618
-
Rosenberg ES, Barocas JA. USPSTF's Hepatitis C Screening Recommendation-A Necessary Step to Tackling an Evolving Epidemic. JAMA Netw Open. 2020 03 02; 3(3):e200538.
Score: 0.570
-
Barocas JA, Tasillo A, Eftekhari Yazdi G, Wang J, Vellozzi C, Hariri S, Isenhour C, Randall L, Ward JW, Mermin J, Salomon JA, Linas BP. Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States. Clin Infect Dis. 2018 08 01; 67(4):549-556.
Score: 0.511
-
Barocas JA, Wang J, White LF, Tasillo A, Salomon JA, Freedberg KA, Linas BP. Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations. Health Aff (Millwood). 2017 12; 36(12):2142-2150.
Score: 0.488
-
Grebely J, Collins AB, Artenie AA, Sutherland R, Meyer JP, Barocas JA, Falade-Nwulia O, Cepeda JA, Cunningham EB, Hajarizadeh B, Lafferty L, Lazarus JV, Bonn M, Marshall AD, Treloar C. Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs. Int J Drug Policy. 2021 10; 96:103469.
Score: 0.159
-
Serota DP, Barocas JA, Springer SA. Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases. Clin Infect Dis. 2020 02 14; 70(5):968-972.
Score: 0.142
-
Barocas JA, Morgan JR, Fiellin DA, Schackman BR, Eftekhari Yazdi G, Stein MD, Freedberg KA, Linas BP. Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids. Int J Drug Policy. 2019 10; 72:160-168.
Score: 0.135
-
Springer SA, Barocas JA, Wurcel A, Nijhawan A, Thakarar K, Lynfield R, Hurley H, Snowden J, Thornton A, Del Rio C. Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA's Advocacy Agenda. J Infect Dis. 2020 09 02; 222(Suppl 5):S230-S238.
Score: 0.037
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|